Novonesis Statistics

Total Valuation

Novonesis has a market cap or net worth of GBP 21.68 billion. The enterprise value is 23.14 billion.

Market Cap	21.68B
Enterprise Value	23.14B

Important Dates

The next estimated earnings date is Wednesday, February 26, 2025.

Earnings Date	Feb 26, 2025
Ex-Dividend Date	Aug 30, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.26%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	345.19M

Valuation Ratios

The trailing PE ratio is 90.42.

PE Ratio	90.42
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	34.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 35.02, with an EV/FCF ratio of 43.22.

EV / Earnings	96.52
EV / Sales	8.99
EV / EBITDA	35.02
EV / EBIT	52.50
EV / FCF	43.22

Financial Position

The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.18.

Current Ratio	1.11
Quick Ratio	0.67
Debt / Equity	0.18
Debt / EBITDA	2.53
Debt / FCF	3.15
Interest Coverage	11.54

Financial Efficiency

Return on equity (ROE) is 4.38% and return on invested capital (ROIC) is 4.12%.

Return on Equity (ROE)	4.38%
Return on Assets (ROA)	3.45%
Return on Capital (ROIC)	4.12%
Revenue Per Employee	246,972
Profits Per Employee	22,939
Employee Count	6,756
Asset Turnover	0.32
Inventory Turnover	2.66

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.75% in the last 52 weeks. The beta is 0.54, so Novonesis's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	+16.75%
50-Day Moving Average	410.50
200-Day Moving Average	426.99
Relative Strength Index (RSI)	52.06
Average Volume (20 Days)	73,734

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novonesis had revenue of GBP 2.58 billion and earned 239.76 million in profits. Earnings per share was 0.86.

Revenue	2.58B
Gross Profit	1.20B
Operating Income	445.15M
Pretax Income	311.46M
Net Income	239.76M
EBITDA	565.72M
EBIT	445.15M
Earnings Per Share (EPS)	0.86

Full Income Statement

Balance Sheet

The company has 221.11 million in cash and 1.69 billion in debt, giving a net cash position of -1.47 billion.

Cash & Cash Equivalents	221.11M
Total Debt	1.69B
Net Cash	-1.47B
Net Cash Per Share	n/a
Equity (Book Value)	9.33B
Book Value Per Share	33.57
Working Capital	150.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 755.36 million and capital expenditures -219.93 million, giving a free cash flow of 535.43 million.

Operating Cash Flow	755.36M
Capital Expenditures	-219.93M
Free Cash Flow	535.43M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 46.66%, with operating and profit margins of 17.24% and 9.29%.

Gross Margin	46.66%
Operating Margin	17.24%
Pretax Margin	12.07%
Profit Margin	9.29%
EBITDA Margin	21.92%
EBIT Margin	17.24%
FCF Margin	20.74%

Dividends & Yields

This stock pays an annual dividend of 0.46, which amounts to a dividend yield of 0.11%.

Dividend Per Share	0.46
Dividend Yield	0.11%
Dividend Growth (YoY)	-62.10%
Years of Dividend Growth	n/a
Payout Ratio	99.19%
Buyback Yield	0.26%
Shareholder Yield	0.37%
Earnings Yield	1.11%
FCF Yield	2.47%

Dividend Details

Stock Splits

The last stock split was on November 28, 2011. It was a forward split with a ratio of 5.

Last Split Date	Nov 28, 2011
Split Type	Forward
Split Ratio	5

Scores

Novonesis has an Altman Z-Score of 3.78.

Altman Z-Score	3.78
Piotroski F-Score	n/a